Danaher Corporation (DHR) Shares Sold by Parallel Advisors LLC

Paterniano Del Favero
Agosto 8, 2017

State Treasurer State Of Michigan owns 0.37% invested in Danaher Corporation (NYSE:DHR) for 604,847 shares. Shayne & Co. Llc owns 7,808 shares or 1.44% of their U.S. portfolio. Kentucky Retirement Systems Insurance Trust Fund bought a new position in shares of Danaher Corporation during the fourth quarter worth $1,534,000. Rehmann Capital Advisory Group now owns 2,959 shares of the conglomerate's stock worth $253,000 after buying an additional 19 shares during the last quarter. Rehmann Capital Advisory Group increased its stake in shares of Danaher Corporation by 0.6% in the first quarter. Parnassus Investments CA now owns 8,622,528 shares of the conglomerate's stock valued at $712,738,000 after buying an additional 1,143,284 shares during the last quarter. The Violich Capital Management Inc holds 78,107 shares with $6.54 million value, up from 65,915 last quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,604,313 shares of the conglomerate's stock worth $137,366,000 after buying an additional 17,500 shares during the last quarter. Dodge And Cox has 0.36% invested in Danaher Corporation (NYSE:DHR) for 5.22M shares. Dimensional Fund Advisors LP now owns 4,661,469 shares of the conglomerate's stock worth $398,696,000 after buying an additional 703,224 shares during the last quarter. ClariVest Asset Management LLC acquired a new stake in shares of Danaher Corporation during the first quarter valued at $157,000. Chesley Taft And Ltd owns 158,107 shares for 1.22% of their portfolio. Institutional investors own 76.56% of the company's stock. Northstar Asset Ltd Liability Corporation accumulated 58,143 shares or 2.04% of the stock. About 605,599 shares traded. The stock has a market capitalization of $56.28 billion, a P/E ratio of 25.86 and a beta of 1.03. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.01. The company's 50 day moving average price is $83.93 and its 200 day moving average price is $84.29. More interesting news about Danaher Corporation (NYSE:DHR) were released by: Nasdaq.com and their article: "Eastern Bank Buys Guggenheim BulletShares 2019 Corporate Bond, Danaher Corp ..." published on July 28, 2017 as well as Fool.com's news article titled: "After Disappointing Earnings, Is Danaher Corporation Still Worth Investing In?" with publication date: July 25, 2017. The conglomerate reported $0.99 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.30% and a return on equity of 11.82%. The firm had revenue of $4.51 billion during the quarter, compared to analysts' expectations of $4.50 billion. On average, equities research analysts forecast that Danaher Corporation will post $3.95 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, July 28th. Investors with a record date on early Fri, Jun 30th were given a $0.14 dividend. The rating was maintained by Deutsche Bank with "Buy" on Wednesday, June 21. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.69%. Moreover, Wilbanks Smith And Thomas Asset Mngmt Limited Liability Company has 0.12% invested in Danaher Corporation (NYSE:DHR). If you are reading this report on another domain, it was illegally stolen and reposted in violation of USA and global trademark & copyright laws. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/08/06/danaher-corporation-dhr-shares-bought-by-page-arthur-b.html. Barclays Capital maintained the shares of DHR in report on Monday, April 18 with "Overweight" rating. Wells Fargo & Company reaffirmed a "market perform" rating on shares of Danaher Corporation in a research note on Saturday, July 22nd.

Among 16 analysts covering Danaher Corporation (NYSE:DHR), 11 have Buy rating, 0 Sell and 5 Hold. Zacks Investment Research lowered Danaher Corporation from a buy rating to a hold rating in a report on Thursday, July 27th. Finally, William Blair reissued an outperform rating on shares of Danaher Corporation in a report on Sunday, April 23rd. Janney Montgomery Scott downgraded shares of Danaher Corporation from a "buy" rating to a "neutral" rating in a report on Wednesday, June 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of "Buy" and an average price target of $91.76. $891,620 worth of Danaher Corporation (NYSE:DHR) shares were sold by SCHWIETERS JOHN T. Another trade for 10,250 shares valued at $882,443 was made by COMAS DANIEL L on Monday, February 27. Jefferies restated a "buy" recommendation and given a $95.00 price objective on the stock of Danaher Corporation in a study note on early Friday. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Donald J. Ehrlich acquired 600 shares of Danaher Corporation stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $83.03, for a total transaction of $878,291.34. Following the sale, the insider now owns 155,520 shares of the company's stock, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. The institutional investor owned 686,420 shares of the conglomerate's stock after selling 16,150 shares during the period.

RBC Capital Markets maintained Danaher Corporation (NYSE:DHR) rating on Friday, October 23. The corporation operates through four segments: Life Sciences, which offers a range of analysis tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of firm, including water quality and product identification.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE